Elevated levels of CD16+ subsets have been observed in patients with AAA (9), and a recent study showed that only intermediate monocytes (CD14++CD16+) were elevated in AAA patients compared to healthy individuals and peripheral artery disease (PAD) patients (10). Here, CD14 is linked to triple-A syndrome.